Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Cohance Lifesciences Management Change

Cohance Lifesciences appointed Umang Vohra as Executive Chairman (effective May 1, 2026) and Group CEO (effective May 20, 2026). He succeeds Vivek Sharma, who is stepping down for personal reasons but will remain as an advisor for nine months to ensure a smooth transition. Mr. Vohra previously served as MD and CEO of Cipla.

Source

BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cohance Lifesciences Ltd: key numbers

Share price
₹476.05
Market cap
₹18,214 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
171.4×Sector 46.1×
Promoter holding
57.48%-0.01% QoQ
FII holding
7.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cohance Lifesciences Ltd

All →

Other management change announcements

All →